Karen Rex

5.6k total citations
32 papers, 1.6k citations indexed

About

Karen Rex is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Karen Rex has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Hepatology and 13 papers in Oncology. Recurrent topics in Karen Rex's work include Liver physiology and pathology (16 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Karen Rex is often cited by papers focused on Liver physiology and pathology (16 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Karen Rex collaborates with scholars based in United States, Netherlands and India. Karen Rex's co-authors include Angela Coxon, Teresa L. Burgess, Catherine L. Farrell, Robert Radinsky, Richard Kendall, Jilin Sun, Jan Sun, David L. Lacey, CS Potten and Christopher DiPalma and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.

In The Last Decade

Karen Rex

31 papers receiving 1.5k citations

Peers

Countries citing papers authored by Karen Rex

Since Specialization

Citations

This map shows the geographic impact of Karen Rex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Rex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Rex more than expected).

Fields of papers citing papers by Karen Rex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Rex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Rex. The network helps show where Karen Rex may publish in the future.

Co-authorship network of co-authors of Karen Rex

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Rex. A scholar is included among the top collaborators of Karen Rex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Rex. Karen Rex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	KRAS inhibition triggers coordinated neoplastic and immune remodeling in the tumor microenvironment 2024 ·The Journal of Immunology ·Daniel Lu, Tao Osgood, Shining Ma, Juan Estrada, (unknown), Tracy Yamawaki, Uyen Hoang, Karen Rex, Jason DeVoss, Jude Canon, (unknown), Songli Wang, Angela Coxon, Chi-Ming Li	0
2	Xenografted Tumors Share Comparable Fraction Unbound and Can Be Surrogated by Mouse Lung Tissue 2024 ·Drug Metabolism and Disposition ·Min Wang, (unknown), (unknown), (unknown), Karen Rex, Tao Osgood, Jan L. Wahlstrom, Upendra P. Dahal	1
3	Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling 2023 ·Cancers ·Franco Cecchi, Karen Rex, (unknown), Cathy D. Vocke, Young Ho Lee, Sandra Burkett, D. N. Baker, Michael A. Damore, Angela Coxon, Teresa L. Burgess, Donald P. Bottaro	3
4	Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma 2019 ·Molecular Cancer Therapeutics ·May Elbanna, Ashley Orillion, Nur P. Damayanti, Remi Adelaiye‐Ogala, Li Shen, Kiersten Marie Miles, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, Sheng‐Yu Ku, Karen Rex, Sean Caenepeel, Angela Coxon, Роберто Пили	10
5	Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRAS^G12C 2019 ·Anne Y. Saiki, Kevin Gaida, Karen Rex, Pragathi Achanta, Tisha San Miguel, Neelima Koppada, Dhanashri Bagal, Brian A. Lanman, R. Foti, John D. McCarter, Laurie P. Volak, Jude Canon, Victor J. Cee, (unknown)	1
6	Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor Plasticity 2017 ·Molecular Cancer Research ·(unknown), Anna C. Navis, Tessa J.J. de Bitter, Houshang Amiri, Kiek Verrijp, Arend Heerschap, Karen Rex, Isabelle Dussault, Sean Caenepeel, Angela Coxon, Paul N. Span, Pieter Wesseling, Wiljan Hendriks, William P. J. Leenders	6
7	Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma 2016 ·Molecular Cancer Therapeutics ·Zhiqiang Du, Sean Caenepeel, Yuqing Shen, Karen Rex, Yanni Zhang, Ying He, En‐Tzu Tang, (unknown), Wenge Zhong, Hui Zhou, (unknown), Eric Huang, Liaoyuan A. Hu, Angela Coxon, (unknown)	18
8	In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models 2016 ·Molecular Cancer Therapeutics ·Paul E. Hughes, Karen Rex, Sean Caenepeel, Yajing Yang, Yihong Zhang, Martin A. Broome, Hue T. Kha, Teresa L. Burgess, Benny Amore, Paula Kaplan‐Lefko, Jodi Moriguchi, Jonathan Werner, Michael A. Damore, D. N. Baker, Deborah M. Choquette, Jean-Christophe Harmange, Robert Radinsky, Richard Kendall, Isabelle Dussault, Angela Coxon	44
9	Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft model 2013 ·Nuclear Medicine and Biology ·Karen Rex, Xiaoman Lewis, Gobalakrishnan Sundaresan, Charles Glaus, (unknown), Robert Radinsky, Teresa L. Burgess, Sanjiv S. Gambhir, Angela Coxon	7
10	Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives 2012 ·Journal of Medicinal Chemistry ·Mark H. Norman, Longbin Liu, Matthew Lee, Ning Xi, I.M. Fellows, Noel D. D’Angelo, Celia Dominguez, Karen Rex, Steven F. Bellon, Tae‐Seong Kim, Isabelle Dussault	90
11	Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Christiane Bode, Alessandro A. Boezio, Brian K. Albrecht, Steven F. Bellon, Loren Berry, Martin A. Broome, Deborah M. Choquette, Isabelle Dussault, Richard T. Lewis, Min-Hwa Jasmine Lin, Karen Rex, Douglas A. Whittington, Yajing Yang, Jean-Christophe Harmange	16
12	Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma 2009 ·Molecular Cancer Therapeutics ·Chong Gao, Qian Xie, (unknown), Yanli Su, Ping Zhao, Brian Cao, Kyle Furge, Jan Sun, Karen Rex, Tao Osgood, Angela Coxon, Teresa L. Burgess, George F. Vande Woude	34
13	Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo 2008 ·Cancer Research ·Yihong Zhang, Paula Kaplan‐Lefko, Karen Rex, Yajing Yang, Jodi Moriguchi, Tao Osgood, (unknown), Angela Coxon, (unknown), Tae‐Seong Kim, Jasmine Lin, April Chen, Teresa L. Burgess, Isabelle Dussault	47
14	Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results 2008 ·Cancer Research ·Angela Coxon, Karen Rex, Jan Sun, Jodi Moriguchi, (unknown), Mark Ma, Abraham Anderson, Yun Lan, Michael A. Gordon, Lia Gore, Christopher Sweeney, Lucy Yan, Darrin M. Beaupre, Kelly S. Oliner, Teresa L. Burgess	2
15	Identification and characterization of a novel RON/c-Met small molecule inhibitor 2007 ·Molecular Cancer Therapeutics ·Yihong Zhang, Paula Kaplan‐Lefko, Karen Rex, Yajing Yang, Jodi Moriguchi, Tao Osgood, (unknown), Angela Coxon, Teresa L. Burgess, Isabelle Dussault	2
16	c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations 2007 ·Journal of Biological Chemistry ·Steven F. Bellon, Paula Kaplan‐Lefko, Yajing Yang, Yihong Zhang, Jodi Moriguchi, Karen Rex, Carol W. Johnson, Paul Rose, Alexander Long, Anne O’Connor, Yan Gu, Angela Coxon, Tae‐Seong Kim, Andrew S. Tasker, Teresa L. Burgess, Isabelle Dussault	113
17	A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Luís Borges, Karen Rex, (unknown), Ping Wei, Stephen A. Kaufman, Sheila Scully, James K. Pretorius, Catherine L. Farrell	23
18	Inhibition of interleukin‐1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis 2002 ·Arthritis & Rheumatism ·Angela Coxon, Brad Bolon, Juan Estrada, Stephen A. Kaufman, Sheila Scully, (unknown), Diane Duryea, Yiling Hu, Karen Rex, Efrain Pacheco, Gwyneth Van, Debra Zack, Ulrich Feige	74
19	The effects of keratinocyte growth factor in preclinical models of mucositis 2002 ·Cell Proliferation ·Catherine L. Farrell, Karen Rex, (unknown), (unknown), Christopher DiPalma, Steve Kaufman, (unknown), Sheila Scully, David L. Lacey	89
20	Influences of neurotrophins on mammalian motoneurons in vivo 1993 ·Journal of Neurobiology ·Yan Qiao, Jeffrey L. Elliott, Christine R. Matheson, Jilin Sun, Li Zhang, Xiaojun Mu, Karen Rex, William D. Snider	172

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact